Results of the TASTE trial TNK non inferior to tPA for disabling strokes selected w perfusion imaging Superiority seen in pooled analysis European Stroke Org #esoc2024

Long awaited! CHARM trial results Does IV glibenclamide help patients with large core stroke? Overall- neutral trial. Check thread for subgroup data European Stroke Org #esoc2024

Pending question in clinical practice- does decompressive craniectomy alone improve outcomes after severe ICH? Somewhat answered European Stroke Org #ESOC2024 SWITCH trial results — no improvement in mRS 0-3, but improved mRS shift at 6 months thelancet.com/journals/lance…

CONVINCE trial shows no definite benefit of colchicine for the primary endpoint. However, there was benefit in on treatment group and in meta-analysis. Publication pending #ESOC2024

🎧 rb.gy/698f5f

Andexanet for FXa Inhibitor–Associated Acute ICH | New England Journal of Medicine nejm.org/do/10.1056/NEJ…

Proud of our #NeurocriticalCare and #Stroke fellows and one of our #NeurocriticalCare APPs on presenting at #NeuroscienceDay today! OSU Department of Neurology and Residency Program The Ohio State University Wexner Medical Center The Ohio State Department of Neuroscience

Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage nejm.org/doi/full/10.10…

Awesome summary from Mica Schachter, MD 🇺🇲🇦🇷!!! These quick guides for recent literature is so fantastic for teaching and remembering! 👏

There is no “i” in Team! Join us for the next SCCM Neuroscience Mentorship Roundtable to hear top insights from our interdisciplinary panel on “Providing Effective Care in a Multidisciplinary Team” 🌟 Zoom link on SCCM Connect! #NeuroICU #Mentorship

Thanks for sharing this case Neurocritical Care! Here's a link to a #tweetorial highlighting some of the 🔑 teaching points: x.com/DanHarrisonMD/…

Important work from Nicholas Morris. Anecdotally have seen performance in code simulations enhanced by ACLS smartphone apps. Would love to see a neuroemergency app next! AI CDS like Glass Health could fill this gap

ELAN trial post-hoc analysis: Early DOAC treatment after ischemic strokes was not associated with a higher rate of adverse events, especially sICH, regardless of infarct size group. Persons with major stroke seem to benefit most (OR 0.52 (0.21 to 1.18)). ja.ma/3wHuMr2

Work in an ED where fentanyl/xylazine use is prevalent and pts present with AMS or are unresponsive despite multiple doses of Narcan? do a neuro exam and get a CT/CTA! You could be missing a stroke or CHANTER syndrome! I've seen CHANTER syndrome 3x this year, all got SOCs.

TRACEIII published (⁦NEJM)⁩ showing benefit of giving TNK up to 24 hrs when don’t have access to EVT for LVO #stroke #neurology #MedEd nejm.org/doi/full/10.10…

Congrats to this all star group! Feels like we just started our respective intern years! Will never forget doing one of my first LPs with Toop or finding an LVO on a reported SAH and getting the shortest door to groin time with Amon Zakeri! What a time it’s been! Congrats again 🎉

CVC troubleshooting 101 for new residents and crit care fellows!

PREOXI trial: Researchers evaluated whether preoxygenation with noninvasive ventilation would be more effective in decreasing the risk of hypoxemia than preoxygenation with an oxygen mask among critically ill adults undergoing endotracheal intubation. nej.md/45lC0xt

With new interns starting residency this week, it's a great time to share some of the most popular #ICUOnePagers. A 🧵

Excited for this!